BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 35406730)

  • 1. Alterations in Protein Translation and Carboxylic Acid Catabolic Processes in Diabetic Kidney Disease.
    Collins KS; Eadon MT; Cheng YH; Barwinska D; Melo Ferreira R; McCarthy TW; Janosevic D; Syed F; Maier B; El-Achkar TM; Kelly KJ; Phillips CL; Hato T; Sutton TA; Dagher PC
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell transcriptomic profiles in the pathophysiology within the microenvironment of early diabetic kidney disease.
    Tsai YC; Kuo MC; Huang JC; Chang WA; Wu LY; Huang YC; Chang CY; Lee SC; Hsu YL
    Cell Death Dis; 2023 Jul; 14(7):442. PubMed ID: 37460555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalin ameliorates renal fibrosis by upregulating CPT1α-mediated fatty acid oxidation in diabetic kidney disease.
    Hu H; Li W; Hao Y; Peng Z; Zou Z; Liang W
    Phytomedicine; 2024 Jan; 122():155162. PubMed ID: 37922789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of potential biomarkers for diabetic kidney disease based on single-cell RNA-sequencing integrated with a single-cell sequencing assay for transposase-accessible chromatin.
    Shi Y; Guo Z; Liu F; Pan S; Gao D; Zhou S; Liu Z; Wang F; Liu D; Liu Z
    Aging (Albany NY); 2023 Oct; 15(19):10681-10704. PubMed ID: 37827693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The single-cell landscape of kidney immune cells reveals transcriptional heterogeneity in early diabetic kidney disease.
    Fu J; Sun Z; Wang X; Zhang T; Yuan W; Salem F; Yu SM; Zhang W; Lee K; He JC
    Kidney Int; 2022 Dec; 102(6):1291-1304. PubMed ID: 36108806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease.
    Majumder S; Hadden MJ; Thieme K; Batchu SN; Niveditha D; Chowdhury S; Yerra VG; Advani SL; Bowskill BB; Liu Y; Vakili H; Alghamdi TA; White KE; Geldenhuys L; Siddiqi FS; Advani A
    Diabetologia; 2019 Nov; 62(11):2129-2142. PubMed ID: 31399844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative transcriptomic profiling of a mouse model of hypertension-accelerated diabetic kidney disease.
    Sembach FE; Ægidius HM; Fink LN; Secher T; Aarup A; Jelsing J; Vrang N; Feldt-Rasmussen B; Rigbolt KTG; Nielsen JC; Østergaard MV
    Dis Model Mech; 2021 Oct; 14(10):. PubMed ID: 34494644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.
    Zhang D; Yang H; Kong X; Wang K; Mao X; Yan X; Wang Y; Liu S; Zhang X; Li J; Chen L; Wu J; Wei M; Yang J; Guan Y
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E287-95. PubMed ID: 20959534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted deletion of von-Hippel-Lindau in the proximal tubule conditions the kidney against early diabetic kidney disease.
    Kunke M; Knöfler H; Dahlke E; Zanon Rodriguez L; Böttner M; Larionov A; Saudenova M; Ohrenschall GM; Westermann M; Porubsky S; Bernardes JP; Häsler R; Magnin JL; Koepsell H; Jouret F; Theilig F
    Cell Death Dis; 2023 Aug; 14(8):562. PubMed ID: 37626062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated ALOX12 in renal tissue predicts progression in diabetic kidney disease.
    Wang M; Wang J; Wang J; Wu Y; Qi X
    Ren Fail; 2024 Dec; 46(1):2313182. PubMed ID: 38345057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
    Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
    Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of the human kidney interstitium in health and disease.
    Barwinska D; El-Achkar TM; Melo Ferreira R; Syed F; Cheng YH; Winfree S; Ferkowicz MJ; Hato T; Collins KS; Dunn KW; Kelly KJ; Sutton TA; Rovin BH; Parikh SV; Phillips CL; Dagher PC; Eadon MT;
    Sci Adv; 2021 Feb; 7(7):. PubMed ID: 33568476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparate phospho-Smad2 levels in advanced type 2 diabetes patients with diabetic nephropathy and early experimental db/db mouse model.
    Thomsen LH; Fog-Tonnesen M; Nielsen Fink L; Norlin J; García de Vinuesa A; Hansen TK; de Heer E; Ten Dijke P; Rosendahl A
    Ren Fail; 2017 Nov; 39(1):629-642. PubMed ID: 28805484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micheliolide ameliorates diabetic kidney disease by inhibiting Mtdh-mediated renal inflammation in type 2 diabetic db/db mice.
    Liu W; Chen X; Wang Y; Chen Y; Chen S; Gong W; Chen T; Sun L; Zheng C; Yin B; Li S; Luo C; Huang Q; Xiao J; Xu Z; Peng F; Long H
    Pharmacol Res; 2019 Dec; 150():104506. PubMed ID: 31669149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephropathy Is Aggravated by Fatty Acids in Diabetic Kidney Disease through Tubular Epithelial Cell Necroptosis and Is Alleviated by an RIPK-1 Inhibitor.
    Yu Q; Chen Y; Zhao Y; Huang S; Xin X; Jiang L; Wang H; Wu W; Qu L; Xiang C; Wang S; Liu G; Yang L
    Kidney Dis (Basel); 2023 Oct; 9(5):408-423. PubMed ID: 37927402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome analysis of human diabetic kidney disease.
    Woroniecka KI; Park AS; Mohtat D; Thomas DB; Pullman JM; Susztak K
    Diabetes; 2011 Sep; 60(9):2354-69. PubMed ID: 21752957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acids and inflammatory stimuli induce expression of long-chain acyl-CoA synthetase 1 to promote lipid remodeling in diabetic kidney disease.
    Wang CH; Surbhi ; Goraya S; Byun J; Pennathur S
    J Biol Chem; 2024 Jan; 300(1):105502. PubMed ID: 38016515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin system inhibition reverses the altered triacylglycerol metabolic network in diabetic kidney disease.
    Sas KM; Lin J; Wang CH; Zhang H; Saha J; Rajendiran TM; Soni T; Nair V; Eichinger F; Kretzler M; Brosius FC; Michailidis G; Pennathur S
    Metabolomics; 2021 Jul; 17(7):65. PubMed ID: 34219205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The deacylase sirtuin 5 reduces malonylation in nonmitochondrial metabolic pathways in diabetic kidney disease.
    Baek J; Sas K; He C; Nair V; Giblin W; Inoki A; Zhang H; Yingbao Y; Hodgin J; Nelson RG; Brosius FC; Kretzler M; Stemmer PM; Lombard DB; Pennathur S
    J Biol Chem; 2023 Mar; 299(3):102960. PubMed ID: 36736426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Renin in Patients and Mice With Diabetic Kidney Disease.
    Tang J; Wysocki J; Ye M; Vallés PG; Rein J; Shirazi M; Bader M; Gomez RA; Sequeira-Lopez MS; Afkarian M; Batlle D
    Hypertension; 2019 Jul; 74(1):83-94. PubMed ID: 31079532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.